Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

ZFP213 Inhibitors

ZFP213 inhibitors are a class of compounds specifically designed to target zinc finger protein 213 (ZFP213), a transcription factor involved in the regulation of gene expression. Like other zinc finger proteins, ZFP213 contains zinc finger motifs, which are structural domains that allow the protein to bind to specific DNA sequences within gene promoter regions. These zinc finger motifs depend on zinc ions to maintain their three-dimensional structure, which is critical for the protein's ability to recognize and interact with DNA. ZFP213 plays an important role in modulating the transcription of various genes, impacting cellular functions and processes. Inhibitors of ZFP213 work by interfering with this DNA-binding activity, either by destabilizing the zinc finger motifs or preventing the protein from interacting with DNA, ultimately affecting the regulation of target genes controlled by ZFP213.

The mechanisms through which ZFP213 inhibitors function can vary. Some inhibitors may work by chelating the zinc ions that are crucial for maintaining the structural stability of the zinc finger motifs. By binding to these zinc ions, the inhibitors cause the zinc finger domains to lose their conformation, which in turn prevents ZFP213 from effectively binding to DNA. This loss of DNA-binding capability disrupts the transcriptional regulation of genes under ZFP213's control. Other inhibitors may block key interactions between ZFP213 and other proteins or cofactors necessary for forming transcriptional complexes, thereby hindering the protein's role in gene regulation. Research into ZFP213 inhibitors is important for expanding our understanding of how zinc finger proteins control complex gene networks and for uncovering the mechanisms that regulate transcriptional processes critical for maintaining cellular homeostasis and function.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Actinomycin D inhibits RNA synthesis by intercalating into DNA, thus preventing transcription, potentially impacting the expression of ZNF213.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$51.00
$231.00
$523.00
63
(1)

Etoposide inhibits topoisomerase II, leading to DNA damage and potential effects on transcription, which could impact the expression of ZNF213.

Cyclosporin A

59865-13-3sc-3503
sc-3503-CW
sc-3503A
sc-3503B
sc-3503C
sc-3503D
100 mg
100 mg
500 mg
10 g
25 g
100 g
$63.00
$92.00
$250.00
$485.00
$1035.00
$2141.00
69
(5)

Cyclosporin A inhibits calcineurin, a phosphatase involved in the activation of T cells. It may indirectly influence ZNF213 expression through immunosuppressive effects.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A is a histone deacetylase inhibitor, potentially impacting chromatin structure and gene expression, including the expression of ZNF213.

Puromycin dihydrochloride

58-58-2sc-108071
sc-108071B
sc-108071C
sc-108071A
25 mg
250 mg
1 g
50 mg
$42.00
$214.00
$832.00
$66.00
394
(16)

Puromycin is an inhibitor of protein synthesis, potentially impacting overall cellular protein levels, including the expression of ZNF213.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

Vorinostat is a histone deacetylase inhibitor, potentially impacting chromatin structure and gene expression, including the expression of ZNF213.

Bleomycin

11056-06-7sc-507293
5 mg
$275.00
5
(0)

Bleomycin induces DNA strand breaks and can impact transcription, potentially influencing the expression of ZNF213.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

Azacitidine is a DNA methyltransferase inhibitor, potentially impacting DNA methylation patterns and gene expression, including the expression of ZNF213.

Mitomycin C

50-07-7sc-3514A
sc-3514
sc-3514B
2 mg
5 mg
10 mg
$66.00
$101.00
$143.00
85
(5)

Mitomycin C crosslinks DNA, leading to DNA damage and potential effects on transcription, which could impact the expression of ZNF213.

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$58.00
$186.00
$94.00
21
(2)

Camptothecin inhibits topoisomerase I, leading to DNA damage and potential effects on transcription, potentially impacting the expression of ZNF213.